SKYLUMYS
Dead / Abandoned — Abandoned — no statement of use filed (as of 24 Mar 2025)
What this means for you
This application is over — abandoned 24 Mar 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98197447
- Mark type
- Stylized text
- Filed
- 26 Sept 2023
- Published for opposition
- 25 Jun 2024
- Abandoned
- 24 Mar 2025
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, mitochondrial diseases, seizure disorders, and neuropsychiatric disorders; pharmaceutical preparations for the treatment of neuromuscular, psychiatric, mitochondrial, ophthalmological, and dermatological diseases and disorders, and epilepsy; none of the foregoing including pharmaceutical preparations for the treatment of pain
Owner
- Reata Pharmaceuticals, Inc., Irving, TX, US
- Reata Pharmaceuticals, Inc., Irving, TX, US
Prosecution history
- 24 Mar 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 24 Mar 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 20 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jun 2024 — PUBLISHED FOR OPPOSITION
- 05 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 May 2024 — ASSIGNED TO EXAMINER
- 11 Oct 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 29 Sept 2023 — NEW APPLICATION ENTERED